Main Session
Sep 30
QP 12 - CNS 4: Quick Pitch: Trials, Toxicity, and Translational Updates in CNS

1070 - Induction-Concurrent Chemoradiotherapy with or without Camrelizumab for Postoperative Residual High-Grade Gliomas: An Open, Randomized, Phase II Clinical Study

04:45pm - 04:55pm PT

Presenter(s)

Guiying Huang, - The Affiliated Cancer Hospital of Guizhou Medical University, Guizhou Province, Guizhou Province